These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 15880743
1. Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes. Ariano MA, Wagle N, Grissell AE. J Neurosci Res; 2005 Jun 01; 80(5):634-45. PubMed ID: 15880743 [Abstract] [Full Text] [Related]
2. Striatal neurochemical changes in transgenic models of Huntington's disease. Ariano MA, Aronin N, Difiglia M, Tagle DA, Sibley DR, Leavitt BR, Hayden MR, Levine MS. J Neurosci Res; 2002 Jun 15; 68(6):716-29. PubMed ID: 12111832 [Abstract] [Full Text] [Related]
3. Striatal potassium channel dysfunction in Huntington's disease transgenic mice. Ariano MA, Cepeda C, Calvert CR, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS. J Neurophysiol; 2005 May 15; 93(5):2565-74. PubMed ID: 15625098 [Abstract] [Full Text] [Related]
4. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Calabresi P, Centonze D, Pisani A, Sancesario G, Gubellini P, Marfia GA, Bernardi G. Ann Neurol; 1998 May 15; 43(5):586-97. PubMed ID: 9585352 [Abstract] [Full Text] [Related]
13. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations. Crocker SF, Costain WJ, Robertson HA. Brain Res; 2006 May 09; 1088(1):176-86. PubMed ID: 16626669 [Abstract] [Full Text] [Related]
14. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Huot P, Lévesque M, Parent A. Brain; 2007 Jan 09; 130(Pt 1):222-32. PubMed ID: 17142832 [Abstract] [Full Text] [Related]
18. The fate of the large striatal interneurons expressing calretinin in Huntington's disease. Massouh M, Wallman MJ, Pourcher E, Parent A. Neurosci Res; 2008 Dec 09; 62(4):216-24. PubMed ID: 18801393 [Abstract] [Full Text] [Related]
19. Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's disease. Ali NJ, Levine MS. Dev Neurosci; 2006 Dec 09; 28(3):230-8. PubMed ID: 16679770 [Abstract] [Full Text] [Related]
20. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Fan MM, Raymond LA. Prog Neurobiol; 2007 Apr 09; 81(5-6):272-93. PubMed ID: 17188796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]